CCL17 and atherosclerosis: Moreover, we (Ye et al., 2017; Ye et al., 2015; Ye et al., 2014) and other studies (Weber et al., 2011; Zernecke and Weber, 2014) have demonstrated that chemokine CCL17, an important regulator of atherosclerosis, is positively associated with coronary artery disease, independent of traditional cardiovascular risk factors.